Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 86
  • Home
  • Print this page
  • Email this page

    Article Cited by others

REVIEW ARTICLE

Immune checkpoint inhibitors: An innovation in immunotherapy for the treatment and management of patients with cancer

Dine Jennifer, Gordon RuthAnn, Shames Yelena, Kasler Mary Kate, Barton-Burke Margaret

Year : 2017| Volume: 4| Issue : 2 | Page no: 127-135

   This article has been cited by
 
1 Guillain-Barré-like syndrome during pembrolizumab treatment
Stephanie Ong,James Chapman,Gavin Young,Talal Mansy
Muscle & Nerve. 2018;
[Pubmed]  [Google Scholar] [DOI]
2 Data-Driven Methods for Advancing Precision Oncology
Prema Nedungadi,Akshay Iyer,Georg Gutjahr,Jasmine Bhaskar,Asha B. Pillai
Current Pharmacology Reports. 2018;
[Pubmed]  [Google Scholar] [DOI]
3 A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity
Prabhakaran Kumar,Palash Bhattacharya,Bellur S. Prabhakar
Journal of Autoimmunity. 2018;
[Pubmed]  [Google Scholar] [DOI]
4 Addressing New Diagnostic and Treatment Challenges Associated With a New Age of Cancer Treatment
Jason J. Bischof,Carolyn J. Presley,Jeffrey M. Caterino
Annals of Emergency Medicine. 2018;
[Pubmed]  [Google Scholar] [DOI]
5 Immunotherapy Adverse Events, Part 2: The Role of the Primary Care Nurse Practitioner
Fedricker D. Barber
The Journal for Nurse Practitioners. 2018;
[Pubmed]  [Google Scholar] [DOI]
6 Next generation of immune checkpoint therapy in cancer: new developments and challenges
Julian A. Marin-Acevedo,Bhagirathbhai Dholaria,Aixa E. Soyano,Keith L. Knutson,Saranya Chumsri,Yanyan Lou
Journal of Hematology & Oncology. 2018; 11(1)
[Pubmed]  [Google Scholar] [DOI]
7 Characterization of cancer genomic heterogeneity by next-generation sequencing advances precision medicine in cancer treatment
Jialing Zhang,Stephan Stanislaw Späth,Sadie L Marjani,Wengeng Zhang,Xinghua Pan
Precision Clinical Medicine. 2018; 1(1): 29
[Pubmed]  [Google Scholar] [DOI]
8 Ex Vivo Tumor-on-a-Chip Platforms to Study Intercellular Interactions within the Tumor Microenvironment
Vardhman Kumar,Shyni Varghese
Advanced Healthcare Materials. 2018; : 1801198
[Pubmed]  [Google Scholar] [DOI]
9 A review and validation of overall survival extrapolation in health technology assessments of cancer immunotherapy by the National Institute for Health and Care Excellence: how did the initial best estimate compare to trial data subsequently made available?
Ash Bullement,Yang Meng,Miranda Cooper,Dawn Lee,Tara Louise Harding,Chris O’Regan,Raquel Aguiar-Ibanez
Journal of Medical Economics. 2018; : 1
[Pubmed]  [Google Scholar] [DOI]
10 Oncolytic adenovirus: A tool for cancer therapy in combination with other therapeutic approaches
Nasser Hashemi Goradel,Nasir Mohajel,Ziba Veisi Malekshahi,Samira Jahangiri,Masoud Najafi,Bagher Farhood,Keywan Mortezaee,Babak Negahdari,Arash Arashkia
Journal of Cellular Physiology. 2018;
[Pubmed]  [Google Scholar] [DOI]
11 Development of mRNA vaccines and their prophylactic and therapeutic applications
Kyuri Lee,Minjeong Kim,Yunmi Seo,Hyukjin Lee
Nano Research. 2018;
[Pubmed]  [Google Scholar] [DOI]
12 Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Julie R. Brahmer,Christina Lacchetti,Bryan J. Schneider,Michael B. Atkins,Kelly J. Brassil,Jeffrey M. Caterino,Ian Chau,Marc S. Ernstoff,Jennifer M. Gardner,Pamela Ginex,Sigrun Hallmeyer,Jennifer Holter Chakrabarty,Natasha B. Leighl,Jennifer S. Mammen,David F. McDermott,Aung Naing,Loretta J. Nastoupil,Tanyanika Phillips,Laura D. Porter,Igor Puzanov,Cristina A. Reichner,Bianca D. Santomasso,Carole Seigel,Alexander Spira,Maria E. Suarez-Almazor,Yinghong Wang,Jeffrey S. Weber,Jedd D. Wolchok,John A. Thompson
Journal of Clinical Oncology. 2018; 36(17): 1714
[Pubmed]  [Google Scholar] [DOI]
13 Analysis of Vipadenant and Its In Vitro and In Vivo Metabolites via Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometry
Seok-Ho Shin,Min-Ho Park,Jin-Ju Byeon,Byeong Lee,Yuri Park,Nahye Kim,Jangmi Choi,Young Shin
Pharmaceutics. 2018; 10(4): 260
[Pubmed]  [Google Scholar] [DOI]
14 Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary
Julie R. Brahmer,Christina Lacchetti,John A. Thompson
Journal of Oncology Practice. 2018; 14(4): 247
[Pubmed]  [Google Scholar] [DOI]
15 Therapeutic vaccines for high-risk HPV-associated diseases
Aleyo Chabeda,Romana J.R. Yanez,Renate Lamprecht,Ann E. Meyers,Edward P. Rybicki,Inga I. Hitzeroth
Papillomavirus Research. 2018; 5: 46
[Pubmed]  [Google Scholar] [DOI]
16 Nano-pulse stimulation induces potent immune responses, eradicating local breast cancer while reducing distant metastases
Siqi Guo,Yu Jing,Niculina I. Burcus,Brittany P. Lassiter,Royena Tanaz,Richard Heller,Stephen J. Beebe
International Journal of Cancer. 2017;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article